Validation of Positive Effect of Posaconazole Prophylaxis During Induction Chemotherapy in AML: Study of Invasive Aspergillosis Incidence and of Risk Factors On Short and Long-Term Survival.
Mauricette Michallet(Université Claude Bernard Lyon 1), Philippe Vanhems(Université Claude Bernard Lyon 1), Marie-Christine Nicoll(Hôpital Edouard Herriot), Emmanuelle Nicolas‐Virelizier(Hôpital Edouard Herriot), Samira Kraghel(Hospices Civils de Lyon), Giovanna Cannas(Hôpital Edouard Herriot), Nathalie Tedone(Hospices Civils de Lyon), Stéphane Morisset(Lyon 1 Université), Fiorenza Barraco(Hôpital Lyon Sud), Stéphane Picot(Hospices Civils de Lyon), Youcef Chelghoum(Hôpital Edouard Herriot), Mohamed El Hamri(Hospices Civils de Lyon), Xavier Thomas(Hôpital Lyon Sud), Frédérique de Monbrison(Hôpital de la Croix-Rousse), Mohamad Sobh(Ottawa Hospital), Franck E. Nicolini(Hôpital Edouard Herriot), Anne‐Lise Bienvenu(Université Claude Bernard Lyon 1), Hélène Labussière(Hôpital Lyon Sud), Sophie Ducastelle(Hôpital Lyon Sud)
Cited by 2
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547